17-5282491-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The ENST00000537505.6(RABEP1):c.5C>A(p.Ala2Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000087 in 1,149,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000537505.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABEP1 | NM_004703.6 | c.5C>A | p.Ala2Glu | missense_variant | 1/18 | ENST00000537505.6 | NP_004694.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABEP1 | ENST00000537505.6 | c.5C>A | p.Ala2Glu | missense_variant | 1/18 | 1 | NM_004703.6 | ENSP00000445408 | P1 | |
RABEP1 | ENST00000341923.10 | c.5C>A | p.Ala2Glu | missense_variant | 1/17 | 1 | ENSP00000339569 | |||
RABEP1 | ENST00000575475.2 | n.170C>A | non_coding_transcript_exon_variant | 1/14 | 1 | |||||
RABEP1 | ENST00000575991.1 | c.5C>A | p.Ala2Glu | missense_variant | 1/3 | 4 | ENSP00000459550 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 8.70e-7 AC: 1AN: 1149114Hom.: 0 Cov.: 30 AF XY: 0.00000180 AC XY: 1AN XY: 556706
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.5C>A (p.A2E) alteration is located in exon 1 (coding exon 1) of the RABEP1 gene. This alteration results from a C to A substitution at nucleotide position 5, causing the alanine (A) at amino acid position 2 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at